↓ Skip to main content

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Overview of attention for book
Cover of 'Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer: Open Questions for Research
  3. Altmetric Badge
    Chapter 2 Self-Seeding in Cancer
  4. Altmetric Badge
    Chapter 3 Microenvironments dictating tumor cell dormancy.
  5. Altmetric Badge
    Chapter 4 Immunomagnetic Separation Technologies
  6. Altmetric Badge
    Chapter 5 Microfluidic Technologies
  7. Altmetric Badge
    Chapter 6 EPISPOT Assay: Detection of Viable DTCs/CTCs in Solid Tumor Patients
  8. Altmetric Badge
    Chapter 7 Advances in Optical Technologies for Rare Cell Detection and Characterization
  9. Altmetric Badge
    Chapter 8 Size-Based Enrichment Technologies for CTC Detection and Characterization
  10. Altmetric Badge
    Chapter 9 Emerging Technologies for CTC Detection Based on Depletion of Normal Cells.
  11. Altmetric Badge
    Chapter 10 Molecular Assays for the Detection and Characterization of CTCs
  12. Altmetric Badge
    Chapter 11 Multiplex Molecular Analysis of CTCs
  13. Altmetric Badge
    Chapter 12 Circulating DNA and Next-Generation Sequencing
  14. Altmetric Badge
    Chapter 13 Circulating MicroRNAs as Noninvasive Biomarkers in Breast Cancer.
  15. Altmetric Badge
    Chapter 14 Circulating Endothelial Cells and Circulating Endothelial Progenitors
  16. Altmetric Badge
    Chapter 15 DTCs in Breast Cancer: Clinical Research and Practice
  17. Altmetric Badge
    Chapter 16 CTCs in Primary Breast Cancer (I)
  18. Altmetric Badge
    Chapter 17 CTCs in Primary Breast Cancer (II)
  19. Altmetric Badge
    Chapter 18 CTCs in Metastatic Breast Cancer
  20. Altmetric Badge
    Chapter 19 HER2-Positive DTCs/CTCs in Breast Cancer
  21. Altmetric Badge
    Chapter 20 DTCs/CTCs in Breast Cancer: Five Decades Later
  22. Altmetric Badge
    Chapter 21 Challenges in Drug and Biomarker Co-Development
  23. Altmetric Badge
    Chapter 22 Challenges and Opportunities in the Use of CTCs for Companion Diagnostic Development
Attention for Chapter 22: Challenges and Opportunities in the Use of CTCs for Companion Diagnostic Development
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Challenges and Opportunities in the Use of CTCs for Companion Diagnostic Development
Chapter number 22
Book title
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Published in
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2012
DOI 10.1007/978-3-642-28160-0_22
Pubmed ID
Book ISBNs
978-3-64-228159-4, 978-3-64-228160-0
Authors

Elizabeth A. Punnoose, Mark R. Lackner

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 13%
Unknown 7 88%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 50%
Professor > Associate Professor 2 25%
Student > Bachelor 1 13%
Student > Doctoral Student 1 13%
Readers by discipline Count As %
Medicine and Dentistry 5 63%
Engineering 2 25%
Agricultural and Biological Sciences 1 13%